1Al-Bdour M, Al-Latayfeh MM. Risk factors for pterygium in an adult Jordanian population. Acta Ophthalmol Scand, 2004, 82: 64-67.
2Gazzard G, Saw S-M, Farook M, et al. Pterygium in Indonesia:prevalence, severity and risk factors. Br J Ophthalmol , 2002, 86:1341-1346.
3Gallagher MJ, Giannoudis A, Herrington CS, et al. Human papillomavirus in pterygium. Br J Ophthalmol ,2001, 85:782-784.
4Piras F, Moore PS, Ugalde J, et al. Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol, 2003, 87:864-866.
5Chen KH, Hsu WM, Cheng CC, et al. Lack of human papillomavirus in pterygium of Chinese patients from Taiwan. Br J Ophthalmol,2003, 87:1064-1066.
6Islam SI. Wagoner MD. Pterygium in young members of one family. Cornea,2001, 20:708-710.
7Coroneo MT, Girolamo ND, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol, 1999, 10:282-288.
8Girolamo ND, Tedla N, Kumar RK, et al. Culture and characterization of epithelial cells from human pterygia. Br J Ophthalmol,1999,83:1077-1082.
9Shimmura S, Isbioka M, Hanada K, et al. Telomerase activity and p53 expression in pterygia. Invest Ophthalmol Vis Sci, 2000,41:1364-1369.
10Reisman D, McFadden JW, Lu G. Loss of heterozygosity and p53 expression in pterygium. Cancer Lett, 2004, 206:77-83.
